Plasmin degradation of fibrin coatings on synthetic polymer substrates

• Published in: Journal of biomedical materials research 1999-09, Vol.46 (3), p.305-314
• Main Authors: Bense, C. A., Woodhouse, K. A.
• Format: Article
• Language: English
• Subjects: Biological and medical sciences; Chromogenic Compounds; Cross-Linking Reagents; crosslinking; Electrophoresis, Polyacrylamide Gel; enzymatic activity; Fibrin - chemistry; fibrin coating; fibrin degradation products; Fibrinolysin - chemistry; fibrinolysis; Medical sciences; Microscopy, Electron, Scanning; Polyurethanes - chemistry; Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects); Surface Properties; Technology. Biomaterials. Equipments. Material. Instrumentation; Transglutaminases - chemistry
• ISSN: 0021-9304; 1097-4636
• DOI: 10.1002/(SICI)1097-4636(19990905)46:3<305::AID-JBM1>3.0.CO;2-A

The goal of this research was to evaluate the in vitro stability of fibrin coatings on polymeric materials in the presence of plasmin. Factor XIIIa‐crosslinked and noncrosslinked fibrin layers were coated on three different polyurethane substrates: Corethane™, Tegaderm®, and a biodegradable polyurethane, PCL/HDI/Phe. Degradation assays indicated that crosslinking the fibrin coatings enhanced the stability of the coatings on both Tegaderm® and PCL/HDI/Phe; however, the persistence of the coating on the woven Corethane™ was not influenced by crosslinking. Degradation assay results also showed that the fibrin coating on the Corethane™ was significantly less stable than the fibrin coatings on the Tegaderm® and PCL/HDI/Phe films. The chromogenic substrate assay data showed crosslinking did not affect the specific plasmin activity on the coatings; therefore, the increased stability resulting from crosslinking was not achieved through a reduction of fibrinolysis. The plasmin activity on the coated Corethane™ samples was much greater than that on either of the coated flat wound dressing materials. The large surface area of Corethane™, a porous woven vascular graft material, may have had a direct influence on the fibrinolysis of its coatings by providing a large number of tissue‐type plasminogen activator (tPA) binding sites. A thin, crosslinked, fibrin‐coated polyurethane provides a theoretically attractive biomaterial for use in a wound dressing application and should be subject to ongoing research. © 1999 John Wiley & Sons, Inc. J Biomed Mater Res, 46, 305–314, 1999.